Jessica Fye
Stock Analyst at J.P. Morgan
(4.52)
# 1,003
Out of 4,417 analysts
572
Total ratings
54.7%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | n/a | $282.72 | - | 24 | Jun 15, 2026 | |
| INSM Insmed | Rated: Buy | $180 → $179 | $98.45 | +81.82% | 26 | Jun 8, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $226.93 | - | 32 | Jun 2, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | n/a | $262.68 | - | 12 | Jun 2, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $30 | $23.53 | +27.50% | 1 | Feb 3, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | n/a | $230.93 | - | 46 | Nov 13, 2025 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | n/a | $74.31 | - | 28 | Nov 9, 2025 | |
| NKTR Nektar Therapeutics | Maintained: Sell | $30 | $60.92 | -50.76% | 31 | Nov 9, 2025 | |
| DNLI Denali Therapeutics | Maintained: Buy | $26 | $23.49 | +10.69% | 16 | Nov 3, 2025 | |
| STOK Stoke Therapeutics | Maintained: Hold | $15 → $25 | $30.26 | -17.38% | 17 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $55.02 | - | 16 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 → $65 | $68.57 | -5.21% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $23 | $17.85 | +28.85% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $26 → $25 | $61.80 | -59.55% | 20 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $121 → $120 | $92.22 | +30.12% | 29 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $98.99 | - | 23 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $15.78 | -36.61% | 10 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $46.95 | - | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $76 | $33.52 | +126.73% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $517 → $530 | $458.99 | +15.47% | 21 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $52 | $35.49 | +46.52% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $77 | $102.04 | -24.54% | 11 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $35 | $44.51 | -21.37% | 13 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 | $551.47 | -18.40% | 32 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $41.59 | n/a | 3 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $13 | $8.95 | n/a | 18 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $28.55 | n/a | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | n/a | $8.14 | n/a | 13 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.17 | n/a | 18 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $14 | $23.14 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $2.04 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $19 | $2.58 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.7798 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $81.89 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $66 | $154.07 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.50 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $12.54 | n/a | 4 | Feb 8, 2018 |
Alnylam Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $282.72
Upside: -
Insmed
Jun 8, 2026
Rated: Buy
Price Target: $180 → $179
Current: $98.45
Upside: +81.82%
Jazz Pharmaceuticals
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $226.93
Upside: -
BeOne Medicines AG
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $262.68
Upside: -
Aktis Oncology
Feb 3, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $23.53
Upside: +27.50%
Ascendis Pharma
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $230.93
Upside: -
Ionis Pharmaceuticals
Nov 9, 2025
Maintained: Buy
Price Target: n/a
Current: $74.31
Upside: -
Nektar Therapeutics
Nov 9, 2025
Maintained: Sell
Price Target: $30
Current: $60.92
Upside: -50.76%
Denali Therapeutics
Nov 3, 2025
Maintained: Buy
Price Target: $26
Current: $23.49
Upside: +10.69%
Stoke Therapeutics
Nov 3, 2025
Maintained: Hold
Price Target: $15 → $25
Current: $30.26
Upside: -17.38%
Oct 27, 2025
Maintained: Buy
Price Target: n/a
Current: $55.02
Upside: -
Oct 27, 2025
Maintained: Hold
Price Target: $63 → $65
Current: $68.57
Upside: -5.21%
Oct 27, 2025
Maintained: Hold
Price Target: $25 → $23
Current: $17.85
Upside: +28.85%
Oct 23, 2025
Maintained: Sell
Price Target: $26 → $25
Current: $61.80
Upside: -59.55%
Oct 23, 2025
Maintained: Hold
Price Target: $121 → $120
Current: $92.22
Upside: +30.12%
Oct 20, 2025
Maintained: Hold
Price Target: n/a
Current: $98.99
Upside: -
Oct 17, 2025
Maintained: Sell
Price Target: $10
Current: $15.78
Upside: -36.61%
Oct 13, 2025
Maintained: Buy
Price Target: n/a
Current: $46.95
Upside: -
Oct 9, 2025
Maintained: Buy
Price Target: $78 → $76
Current: $33.52
Upside: +126.73%
Oct 8, 2025
Maintained: Buy
Price Target: $517 → $530
Current: $458.99
Upside: +15.47%
Sep 24, 2025
Reiterated: Buy
Price Target: $53 → $52
Current: $35.49
Upside: +46.52%
Sep 12, 2025
Maintained: Buy
Price Target: $53 → $77
Current: $102.04
Upside: -24.54%
Sep 9, 2025
Maintained: Hold
Price Target: $34 → $35
Current: $44.51
Upside: -21.37%
Sep 9, 2025
Maintained: Buy
Price Target: $450
Current: $551.47
Upside: -18.40%
Jun 16, 2025
Maintained: Buy
Price Target: n/a
Current: $41.59
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $10 → $13
Current: $8.95
Upside: n/a
Apr 11, 2025
Maintained: Buy
Price Target: $50
Current: $28.55
Upside: n/a
Nov 20, 2023
Initiated Coverage: Sell
Price Target: n/a
Current: $8.14
Upside: n/a
Nov 20, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $3.17
Upside: n/a
Jun 7, 2022
Maintained: Hold
Price Target: $18 → $14
Current: $23.14
Upside: n/a
Apr 7, 2022
Maintained: Hold
Price Target: $7 → $5
Current: $2.04
Upside: n/a
Mar 14, 2022
Maintained: Buy
Price Target: $20 → $19
Current: $2.58
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.7798
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $81.89
Upside: n/a
Apr 6, 2020
Maintained: Hold
Price Target: $94 → $66
Current: $154.07
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $9.50
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $12.54
Upside: n/a